20 January 2012
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, will announce its results for the fourth quarter and full year ended 31 December 2011 on Thursday 2 February 2012 at 7.00am GMT/2.00am Eastern time. This will be followed by a presentation for financial analysts at 9.00am GMT/4.00am Eastern time, which can be seen live via webcast on the Smith & Nephew website at www.smith-nephew.com and available on the site archive shortly afterwards.
About Us
Smith & Nephew is a global medical technology business with global leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine, Trauma and Clinical Therapies. The Company has distribution channels, purchasing agents and buying entities in over 90 countries worldwide. Annual sales in 2010 were nearly $4.0 billion.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust.
Enquiries:
Investors/Analysts |
|
Kim Gunthorp |
Tel: +44 (0) 207 401 7646 |
Smith & Nephew plc |
|
|
|
Media |
|
Charles Reynolds Smith & Nephew plc
Justine McIlroy Brunswick - London |
Tel: +44 (0) 207 401 7646
Tel: +44 (0) 207 404 5959 |
|
|